ELOXX PHARMACEUTICALS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2026-08-11
- ELOXX PHARMACEUTICALS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-06-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-03-31 was -$21.00K.
- ELOXX PHARMACEUTICALS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-06-30 was -$196.00K.
- ELOXX PHARMACEUTICALS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-03-31 was -$182.00K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$21.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$21.00K 10-Q · filed 2026-05-05 | |
| 2025-06-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$378.00K 10-Q · filed 2026-08-11 |
| 2025-03-31 | -$182.00K 10-Q · filed 2026-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |